"Holy Cross Resource Center offers community members a broad range of classes and activities that promote health and wellness."

During the past decade, Holy Cross Hospital Resource Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Holy Cross Hospital Resource Center" are "Follicular Lymphoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Holy Cross Hospital Resource Center" in a lesser frequency.

Most popular intervention types in "Holy Cross Hospital Resource Center" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab-EU" (1 trials), "Bevacizumab-Pfizer" (1 trials), "Carboplatin" (1 trials), "MabThera®" (1 trials) and "PF-05280586" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holy Cross Hospital Resource Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Holy Cross Hospital Resource Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Holy Cross Hospital Resource Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Holy Cross Hospital Resource Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".